Sign in

Visiopharm

@visiopharm.bsky.social
37 followers 23 following 25 posts

Visiopharm® is a world leader in AI-driven digital precision pathology software.

PostsRepliesMedia
Visiopharm @visiopharm.bsky.social · 19/06/2026
Niklas presenting a demo of #Qualitopix at ECDP in Graz! Qualitopix is a platform that helps laboratories monitor, measure, and document the consistency of immunohistochemistry (IHC) staining - a big challenge in pathology labs.
011
Visiopharm @visiopharm.bsky.social · 17/07/2025
Are you a researcher working with tissue analysis? Join us for The Research Rebellion Tour, a live seminar series across three U.S. cities, where we spotlight how spatial biology, digital pathology, and computational image analysis are helping scientists do more with less. 👉https://hubs.ly/Q03v_nxs0
021
Visiopharm @visiopharm.bsky.social · 09/07/2025
This is not a conference. This is a rebellion. We’re taking AI-driven image analysis on the road — and we’re not holding back. The Research Rebellion Tour is launching soon. Stay tuned! #ResearchRebellionTour
010
Reposted by Visiopharm
Jim Mansfield @jrmansfield.bsky.social · 05/06/2025
Nice to see #IMC and #Phenoplex coming together to investigate immune landscapes. Two great tastes that taste great together. ascopubs.org/doi/abs/10.1... @standardbiology.bsky.social @visiopharm.bsky.social #SpatialProteomics #SpatialBio
ascopubs.org
Immune landscape of sarcoma patients treated with an autologous dendritic cell vaccine.
e23530Background: The role of the sarcoma immune tumor microenvironment (TME) is a critical area of ongoing research, particularly to understand responses to immunotherapy. We previously conducted a p...
021
Visiopharm @visiopharm.bsky.social · 21/05/2025
Last week at the Spatial Biology Congress in The Hague, Netherlands. Bjorn and Roberto presented our #Phenoplex workflow for multiplexed image analysis. Read more: visiopharm.com/research-pat...
000
Visiopharm @visiopharm.bsky.social · 15/05/2025
Join us at the CyTOF Summit in Denver alongside Standard BioTools! Don’t miss Katherine’s talk at 2:45 PM: “A Deep-Learning approach for tissue mapping and cell phenotyping in IMC data analysis”. Register now: cytofsummit2025.eventbrite.com?aff=Visiopharm We’ll see you there!
010
Visiopharm @visiopharm.bsky.social · 15/05/2025
Shuling and Jennifer Ziello presenting our collaborative poster with Cell Signaling Technology at #AACR25
010
Reposted by Visiopharm
Jim Mansfield @jrmansfield.bsky.social · 03/05/2025
An excellent paper by Joel Eliason, Jared K. Burks, Suhendan Ekmekcioglu et al on characterizing the spatial immune architecture in melanoma using imaging mass cytometry #IMC. www.frontiersin.org/journals/imm... @standardbiology.bsky.social @visiopharm.bsky.social #SpatialBio #ImagingMassCytometry
frontiersin.org
022
Visiopharm @visiopharm.bsky.social · 29/04/2025
Live at the Visiopharm User Group Meeting UK! Alexander spencer-Tansley from HistologiX is presenting "Hit and Miss: A fast-labelling approach to detection and classification"
000
Visiopharm @visiopharm.bsky.social · 24/04/2025
Dan Winkowski and Regan Baird are representing Visiopharm at the 10x Genomics user group meeting in Philadelphia! Come by and learn about our partnership to advance spatial biology research.
010
Visiopharm @visiopharm.bsky.social · 16/04/2025
We had the privilege of speaking with Professor David Berman, a leading researcher focused ​on developing​​ high-impact cancer tests for prostate and bladder cancer patients! Read the blog to see how Visiopharm software supports his research: visiopharm.com/blog/improvi...
visiopharm.com
Improving bladder cancer grading with AI-driven image analysis: A conversation with Prof. David Berman - Visiopharm
Prof. Berman shares insights into his team’s efforts to ​improve​​ bladder cancer grading. By using Visiopharm’s AI-driven software, they are automating the analysis of millions of nuclei, creating mo...
000
Visiopharm @visiopharm.bsky.social · 14/04/2025
1 month to go! Join us at our in-person workshop in Paris ✨ Check out the full agenda and register here: hubs.ly/Q038mrxw0
000
Visiopharm @visiopharm.bsky.social · 10/04/2025
We are excited to announce the successful integration of Visiopharm’s Discovery image analysis software into Indica Labs' collaborative image management platform, HALO Link. Press release: visiopharm.com/press-releas...
visiopharm.com
Indica Labs and Visiopharm Deliver an Integrated Digital Pathology Image Management and Analysis Solution - Visiopharm
Indica Labs and Visiopharm announce the successful integration of Visiopharm’s Discovery image analysis software into Indica’s collaborative image management platform, HALO Link.
000
Visiopharm @visiopharm.bsky.social · 01/04/2025
Last week, we joined the “Single-Cell Spatial In Situ Hyperplex Imaging and AI Data Analysis Workshop” at Zhejiang Chinese Medical University, organized by Prof. Georgios Giamas. David Mason presented #Phenoplex, a complete workflow for all your multiplexed image analysis needs 💡
000
Visiopharm @visiopharm.bsky.social · 25/03/2025
Exciting news at #USCAP2025! We’re celebrating 10-year anniversary with ISENET – and marking the occasion with a special announcement: 👉 All new Galileo customers will receive a 3-month trial of Visiopharm’s Tissuearray software. Booth #701
000
Visiopharm @visiopharm.bsky.social · 25/03/2025
Live at #USCAP2025 with our team ready to meet you at booth #701! Come by to see our latest release: Fully automated HER2 algorithm for precise quantification of expression across the complete spectrum.
000
Visiopharm @visiopharm.bsky.social · 24/03/2025
Heading to USCAP today? Join our talk: “The Destiny of HER2: Measure nearly undetectable HER2 levels through precision, not perception” and learn more about our new HER2 solution and its full integration to Proscia’s workflow.
011
Visiopharm @visiopharm.bsky.social · 21/03/2025
Heading to #USCAP2025? Don’t miss this exclusive lunch seminar hosted by Agilent!
010
Visiopharm @visiopharm.bsky.social · 18/03/2025
Webinar today! Join us at 8:00 AM PT / 5:00 PM CET for a webinar in collaboration with Molecular Instruments, where we’ll dive into how AI and Dual-Channel Staining can overcome common bottlenecks in RNA-ISH detection. visiopharm.wistia.com/live/events/...
000
Visiopharm @visiopharm.bsky.social · 04/03/2025
Join our webinar with Molecular Instruments on RNA-ISH spot detection! 📅 March 18, 2025 | 5:00 PM GMT+1 Learn how Dual Channel™ Validation and Visiopharm’s AI-powered Discovery software enhance RNA quantification in complex tissue environments. Register: visiopharm.wistia.com/live/events/...
visiopharm.wistia.com
Enhancing RNA-ISH spot detection with dual-channel staining and AI analysis
Ensuring accurate RNA detection within specific cellular contexts is essential for advancing translational research and clinical applications. However, the lack of robust validation of probes targetin...
000
Visiopharm @visiopharm.bsky.social · 03/03/2025
New publication in Nature Genetics by Prip, F. et al., explores the molecular landscape of nonmuscle-invasive bladder cancer, providing insights to improve risk assessment and treatment regimens. Check out how Visiopharm was used in the research: www.nature.com/articles/s41...
nature.com
Comprehensive genomic characterization of early-stage bladder cancer - Nature Genetics
A genomic and transcriptomic analysis of nonmuscle-invasive bladder cancer identifies four molecular subtypes, and associates whole-genome duplication and immune exhaustion with tumor progression.
021
Visiopharm @visiopharm.bsky.social · 25/02/2025
Join us for an exciting HER2-focused event on April 9th at UMC Utrecht! 🤝 Register now: imageanalysis.visiopharm.com/registration...
011
Visiopharm @visiopharm.bsky.social · 18/02/2025
Join our upcoming Visiopharm User Group Meeting in the UK - a day of learning, networking, and case study presentations from peers. Secure your place now: imageanalysis.visiopharm.com/registration...
011
Visiopharm @visiopharm.bsky.social · 03/02/2025
Join Michael Grunkin at the upcoming webinar hosted by Agilent Technologies for an insightful panel discussion with digital pathology experts from Agilent, Hamamatsu Corporation, Proscia, and PathAI. www.labmanager.com/ai-enhanced-...
011
Visiopharm @visiopharm.bsky.social · 31/01/2025
Are you struggling with cell segmentation in multiplex tissue imaging? This blog post offers valuable insights to help you overcome this challenge! visiopharm.com/blog/a-guide...
000
Visiopharm @visiopharm.bsky.social · 29/01/2025
Curious about the latest in digital pathology and spatial biology? Subscribe to The Intel, Visiopharm's monthly newsletter: visiopharm.com/newsletter-s...
011